{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:46:45Z","timestamp":1776235605761,"version":"3.50.1"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which patients have a significantly increased risk of developing osteoporosis (OP) and osteopenia. Despite numerous studies, the global burden of SLE-related OP, its regional distribution patterns and its major risk factors remain poorly quantified and subject to controversy due to heterogeneity in sample sizes, diagnostic criteria and methodologies. To address these gaps in the evidence, we conducted a systematic assessment of the prevalence and risk factors for OP and osteopenia in patients with SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis. We performed a comprehensive search of Chinese and English databases, including PubMed, Embase, the Cochrane Library, Web of Science, CNKI and WANFANG, up to 26 September 2025. We included observational studies that met the diagnostic criteria for SLE and reported the prevalence of OP or reduced bone mass, as well as associated risk factors. Two reviewers independently conducted literature screening, data extraction and quality assessment. Statistical analysis was performed using Stata 12.0 software; random-effects or fixed-effects models were employed to pool prevalence rates and odds ratios, and subgroup analysis, meta-regression and sensitivity analysis were used to explore sources of heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 59 studies were included. Meta-analysis revealed an overall prevalence of osteoporosis in SLE patients of 16.70% (95% CI: 14.2%, 19.3%) and a prevalence of osteopenia of 39.50% (95% CI: 35.5%, 43.5%). Site-specific analysis indicated that the lumbar spine was the site with the highest prevalence of osteoporosis (10.0%), whilst the femoral neck was the site most commonly affected by osteopenia (44.1%). Subgroup analysis identified several high-risk populations; the prevalence of osteoporosis in postmenopausal women (34.0%) was significantly higher than in premenopausal women (11.6%). Risk factor analysis indicated that advanced age (&amp;gt;50 years, OR\u00a0=\u00a021.92), long-term glucocorticoid use (OR\u00a0=\u00a01.63) and prolonged duration of SLE (OR\u00a0=\u00a01.05) were significant risk factors for OP. Glucocorticoid dosage was positively correlated with risk, with a significant increase in risk observed at daily doses &amp;gt;10 mg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with SLE are at high risk of osteoporosis and osteopenia; postmenopausal women, Asian patients and those on long-term glucocorticoid therapy should be prioritized for screening and intervention. This study has revealed site-specific patterns of skeletal involvement and quantified the impact of key risk factors. In clinical practice, priority should be given to combined bone density monitoring, focusing on the lumbar spine and femoral neck, in high-risk populations. Furthermore, risk-stratified, proactive bone health management strategies should be implemented, with the aim of shifting the focus from \u2018treating fractures\u2019 to \u2018preventing fractures\u2019, thereby improving long-term patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/inplasy.com\/inplasy-2025-12-0043\/<\/jats:ext-link>\n                      , identifier INPLASY2025120043.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1778825","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:44:52Z","timestamp":1776231892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global prevalence, site-specific patterns, and key risk factors for osteoporosis and bone loss in systemic lupus erythematosus: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Chunhui","family":"Yu","sequence":"first","affiliation":[{"name":"The First Clinical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jipeng","family":"Hui","sequence":"additional","affiliation":[{"name":"The Center for Preventive Treatment of Disease, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Ding","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilan","family":"Ma","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]},{"name":"The Third Department of Orthopedics, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.09.012","article-title":"Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis","volume":"95","author":"Nusbaum","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.040","article-title":"GC-induced osteoporosis: an update on effects and management","volume":"132","author":"Buehring","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"GC-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2177-5","article-title":"Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT","volume":"24","author":"Tang","year":"2013","journal-title":"Osteoporos Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000157","article-title":"Independent association of GCs with damage accrual in SLE","volume":"3","author":"Apostolopoulos","year":"2016","journal-title":"Lupus Sci Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211000126","article-title":"The changes in bone turnover markers of female systemic lupus erythematousus patients without GC","volume":"30","author":"Tianle","year":"2021","journal-title":"Lupus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-000968","article-title":"Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density","volume":"10","author":"Shevchuk","year":"2023","journal-title":"Lupus Sci Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.36740\/WLEK202102124","article-title":"Peculiarities of bone mineral density in women of different reproductive age with systemic lupus erythematosus","volume":"74","author":"Shevchuk","year":"2021","journal-title":"Wiad Lek"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/jpem-2021-0496","article-title":"Predictors of decreased bone mineral density in childhood systemic lupus erythematosus: possible role of osteoprotegerin gene polymorphisms","volume":"35","author":"Eid","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3492-6","article-title":"Chronic high-dose GC therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus","volume":"36","author":"Tarr","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-021-00981-w","article-title":"Deescalation and GC-free treatment in SLE","volume":"80","author":"Fischer-Betz","year":"2021","journal-title":"Z Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.018127","article-title":"Prevalence and predictors of fragility fractures in systemic lupus erythematosus","volume":"64","author":"Yee","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308094995","article-title":"Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids","volume":"18","author":"Yeap","year":"2009","journal-title":"Lupus"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309345775","article-title":"Vitamin D insufficiency in a large female SLE cohort","volume":"19","author":"Toloza","year":"2010","journal-title":"Lupus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120213","article-title":"Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm GC therapy","volume":"39","author":"Tang","year":"2012","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/510514","article-title":"Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus","volume":"2015","author":"Sun","year":"2015","journal-title":"BioMed Res Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2011.12.002","article-title":"The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors","volume":"15","author":"Souto","year":"2012","journal-title":"J Clin Densitom"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu1036oa","article-title":"Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density","volume":"13","author":"Pineau","year":"2004","journal-title":"Lupus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1105-3","article-title":"Risk factors of vertebral fractures in women with systemic lupus erythematosus","volume":"28","author":"Mendoza-Pinto","year":"2009"},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10067-008-0984-z","article-title":"Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus","volume":"28","author":"Mendoza-Pinto","year":"2009","journal-title":"Clin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091231","article-title":"Bone microarchitecture assessment by high-resolution peripheral quantitative computed tomography in patients with systemic lupus erythematosus taking corticosteroids","volume":"37","author":"Li","year":"2010","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081337","article-title":"High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus","volume":"36","author":"Li","year":"2009","journal-title":"J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111589","article-title":"Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus","volume":"39","author":"Lee","year":"2012","journal-title":"J Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.afos.2020.11.001","article-title":"Prevalence of osteoporosis in patients with systemic lupus erythematosus: a multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria","volume":"6","author":"Jung","year":"2020","journal-title":"Osteoporos Sarcopenia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-014-9918-8","article-title":"Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT","volume":"95","author":"Hansen","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316664596","article-title":"Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China","volume":"26","author":"Guo","year":"2017","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0286-z","article-title":"Incidence of vertebral fractures in women with systemic lupus erythematosus after 8 years of follow-up","volume":"101","author":"Garc\u00eda-Carrasco","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0735-5","article-title":"Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus","volume":"23","author":"Furukawa","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-005-0644-5","article-title":"Lupus in Germany: analysis within the German lupus self-help organization (LULA)","volume":"64","author":"Fischer-Betz","year":"2005","journal-title":"Z Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316664597","article-title":"Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus","volume":"26","author":"Cramarossa","year":"2017","journal-title":"Lupus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.21110","article-title":"Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus","volume":"52","author":"Bultink","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0743-0","article-title":"Bone mineral density changes in women with systemic lupus erythematosus","volume":"22","author":"Boyanov","year":"2003","journal-title":"Clin Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0258-6","article-title":"Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus","volume":"26","author":"Chong","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem105","article-title":"Prevalence and risk factors of osteoporosis in female SLE patients\u2014extended report","volume":"46","author":"Almehed","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/10998004211005550","article-title":"Disease damage accrual and low bone mineral density in female patients with systemic lupus erythematosus","volume":"23","author":"Correa-Rodr\u00edguez","year":"2021","journal-title":"Biol Res Nurs"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.29089\/2020.20.00117","article-title":"Bone mineral density in women with systemic lupus erythematosus, its association with bone turnover markers, levels of estradiol and interleukin-6","volume":"27","author":"Shevchuk","year":"2020","journal-title":"Polish Ann Med"},{"key":"B38","first-page":"45","article-title":"The effect of long-term GCs on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption","volume":"76","author":"Korczowska","year":"2003","journal-title":"Yale J Biol Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/17423953221138921","article-title":"Comorbidities among Egyptian systemic lupus erythematosus: the COMOSLE-EGYPT study","volume":"19","author":"Gamal","year":"2023","journal-title":"Chronic Illn"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1244-5","article-title":"Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus","volume":"31","author":"Furukawa","year":"2011","journal-title":"Rheumatol Int"},{"key":"B41","article-title":"Analysis of factors affecting bone mineral density changes in premenopausal women with rheumatic diseases","volume-title":"J Pract Med","author":"He","year":"2009"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231202701","article-title":"Fragility fractures in lupus patients: associated factors and comparison of four fracture risk assessment tools","volume":"32","author":"Ceccarelli","year":"2023","journal-title":"Lupus"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000098","article-title":"Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus","volume":"3","author":"Carli","year":"2016","journal-title":"Lupus Sci Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.8.742","article-title":"The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women","volume":"34","author":"Pons","year":"1995"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3109\/s101650200057","article-title":"Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with GCs","volume":"12","author":"Banno","year":"2002","journal-title":"Mod Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/096120330101001108","article-title":"Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage","volume":"10","author":"Becker","year":"2001","journal-title":"Lupus"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211005067","article-title":"Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus","volume":"7","author":"Zhu","year":"2021","journal-title":"Lupus"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2157-9","article-title":"Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus","volume":"24","author":"Jacobs","year":"2013","journal-title":"Osteoporos Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221074451","article-title":"Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study","volume":"14","author":"Mok","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2910-3","article-title":"Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only","volume":"26","author":"Lai","year":"2015","journal-title":"Osteoporos Int"},{"key":"B52","article-title":"Determinants of bone mineral density in systemic lupus erythematosus","volume":"6","author":"Ding","year":"2002","journal-title":"Chin J Rheumatol"},{"key":"B53","first-page":"57","article-title":"The influence of long-term GC use on bone mineral density in premenopausal women with SLE","volume":"12","author":"Liang","year":"2006","journal-title":"Chin J Osteoporosis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-801917-7.00027-9","article-title":"Multivariable statistical analysis of osteoporosis in patients with systemic lupus erythematosus","volume":"8","author":"Shen","year":"2004","journal-title":"Chin J Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-7108.2022.08.014","article-title":"Risk factors of abnormal bone metabolism in female patients with systemic lupus erythematosus","volume":"28","author":"Li","year":"2022","journal-title":"Chin J Osteoporosis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-6450.2013.04.024","article-title":"Bone mineral density measurement and correlation analysis in 42 female patients with systemic lupus erythematosus","volume":"12","author":"Ye","year":"2013","journal-title":"Chin J Difficult Complicated cases"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-52974-1_3","article-title":"Study of bone mineral density in premenopausal women with systemic lupus erythematosus","volume":"33","author":"Zhu","year":"2000","journal-title":"Chin J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.06.005","article-title":"Bone density assessment and management in systemic lupus erythematosus","volume":"15","author":"Liu","year":"2000","journal-title":"J Nurs Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3969\/j.issn.1002-266X.2015.24.035","article-title":"Analysis of serological immunological risk factors for osteoporosis in patients with systemic lupus erythematosus","volume":"55","author":"Hou","year":"2015","journal-title":"Shandong Med J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-5519.2014.18.004","article-title":"Study on the relationship between inflammatory states of SLE and osteoporosis","volume":"30","author":"Luo","year":"2014","journal-title":"J Modern Med Health"},{"key":"B61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13075-025-03610-y","article-title":"Lupus nephritis and U1-RNP-antibodies are associated with low bone mineral density and osteoporosis in patients with systemic lupus erythematosus: baseline findings in a subcohort of patients with inflammatory rheumatic diseases","volume":"27","author":"Wiebe","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131190","article-title":"Bone mineral density change in systemic lupus erythematosus: a 5-year followup study","volume":"41","author":"Zhu","year":"2014","journal-title":"J Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3087-y","article-title":"Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region","volume":"35","author":"Salman-Monte","year":"2015","journal-title":"Rheumatol Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.2.110","article-title":"Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls","volume":"59","author":"Gilboe","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000237","article-title":"Quantifying the burden of steroidrelated damage in SLE in the Hopkins Lupus Cohort","volume":"5","author":"Davidson","year":"2018","journal-title":"Lupus Sci Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001266","article-title":"Real- world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage","volume":"11","author":"Eviatar","year":"2024","journal-title":"Lupus Sci Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.0253-9802.2022.05.013","article-title":"Risk factors of systemic lupus erythematosus complicated with osteoporosis","volume":"53","author":"Sun","year":"2022","journal-title":"J New Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-024-02508-0","article-title":"Risk factors of osteoporosis in patients with systemic lupus erythematosus","volume":"53","author":"Zhong","year":"2023","journal-title":"Xinjiang Med J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160214","article-title":"Cumulative burden of GC-related adverse events in patients with systemic lupus erythematosus: findings from a 12-year longitudinal study","volume":"45","author":"Chen","year":"2018","journal-title":"J Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3029-x","article-title":"RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus","volume":"26","author":"Bonf\u00e1","year":"2015","journal-title":"Osteoporos Int"},{"key":"B71","article-title":"Factors associated with low bone mineral density in female patients with systemic lupus erythematosus","volume":"28","author":"Lakshminarayanan","year":"2001","journal-title":"J Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2011-0","article-title":"Impaired bone mineralization accompanied by low vitamin D and secondary hyperparathyroidism in patients with femoral neck fracture","volume":"24","author":"Seitz","year":"2013","journal-title":"Osteoporos Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2013.06.031","article-title":"Femoral neck bone adaptation to weight-bearing physical activity by computational analysis","volume":"46","author":"MaChado","year":"2013","journal-title":"J Biomech"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxab028","article-title":"Long-term use of glucocorticoid exacerbates bone lesions in postmenopausal women with rheumatoid arthritis","volume":"6","author":"Hatano","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2024.109440","article-title":"A comprehensive review on glucocorticoids induced osteoporosis: a medication caused disease","volume":"207","author":"Rahman","year":"2024","journal-title":"Steroids"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors","volume":"15","author":"Gu","year":"2019","journal-title":"Arch Osteoporos"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0322-z","article-title":"Bone disease in connective tissue disease\/systemic lupus erythematosus","volume":"102","author":"Bultink","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B78","volume-title":"Assessment of osteoporosis report of a WHO scientific group","year":"1994"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11460","article-title":"microRNA-199a counteracts GC inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro","volume":"44","author":"Tang","year":"2020","journal-title":"Cell Biol Int"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211002136","article-title":"Arbutin ameliorates GC-induced osteoporosis through activating autophagy in osteoblasts","volume":"246","author":"Zhang","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137334","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 within osteoclasts mediates the bone protective properties of therapeutic corticosteroids in chronic inflammation","volume":"23","author":"Fenton","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/832127","article-title":"Bone loss triggered by the cytokine network in inflammatory autoimmune diseases","volume":"2015","author":"Amarasekara","year":"2015","journal-title":"J Immunol Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666190821161259","article-title":"TNF-\u03b1 and IL-6: the link between immune and bone system","volume":"21","author":"Wang","year":"2020","journal-title":"Curr Drug Targets"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13122945","article-title":"Tissue-resident memory T cells in rheumatoid immune diseases: pathogenic mechanisms and therapeutic strategies","volume":"13","author":"Tian","year":"2025","journal-title":"Biomedicines"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00019","article-title":"Tissue-specific effects of loss of estrogen during menopause and aging","volume":"3","author":"Wend","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1155\/2021\/2808613","article-title":"Association of high calcitriol serum levels and its hydroxylation efficiency ratio with disease risk in SLE patients with vitamin D deficiency","author":"Meza-Meza","year":"2021","journal-title":"J Immunol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.244.263","article-title":"Interleukin-35 as a new biomarker of renal involvement in lupus nephritis patients","volume":"244","author":"He","year":"2018","journal-title":"Tohoku J Exp Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105804","article-title":"Bone involvement in systemic lupus erythematosus","volume":"23","author":"Rella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313491847","article-title":"Hypercalcemic crisis due to primary hyperparathyroidism in systemic lupus erythematosus (SLE)","volume":"22","author":"Choudhry","year":"2013"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1537","article-title":"Heritability of prevalent vertebral fracture and volumetric bone mineral density and geometry at the lumbar spine in three generations of the Framingham study","volume":"27","author":"Liu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9674-6","article-title":"Glucocorticoid-induced changes in the geometry of osteoclast resorption cavities affect trabecular bone stiffness","volume":"92","author":"Vanderoost","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/art.39726","article-title":"Trabecular bone score in patients with chronic glucocorticoid therapy-induced osteoporosis treated with alendronate or teriparatide","volume":"68","author":"Saag","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.04.013","article-title":"Relationship between serum 25-hydroxyvitamin D and bone mineral density, fracture risk, and bone metabolism in adults with osteoporosis\/fractures","volume":"30","author":"Chen","year":"2024","journal-title":"Endocr Pract"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778825\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:45:02Z","timestamp":1776231902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778825\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":93,"alternative-id":["10.3389\/fimmu.2026.1778825"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1778825","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1778825"}}